Myriad Genetics
MYGN
#6857
Rank
A$0.91 B
Marketcap
A$9.76
Share price
-2.96%
Change (1 day)
-55.33%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2025 (TTM): -A$0.65 Billion

According to Myriad Genetics's latest financial reports the company's current earnings are A$0.82 Billion. In 2024 the company made an earning of -A$0.18 Billion, an increase over its 2023 earnings that were of -A$0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.65 Billion257.49%
2024 -A$0.18 Billion-53.49%
2023 -A$0.39 Billion88.72%
2022 -A$0.21 Billion172.08%
2021 -A$75.17 Million
2019 -A$39.15 Million-175.14%
2018 A$52.09 M-70.81%
2017 A$0.17 B22.22%
2016 A$0.14 B-38.8%
2015 A$0.23 B-6.12%
2014 A$0.25 B-41.07%
2013 A$0.43 B46.67%
2012 A$0.29 B15.84%
2011 A$0.25 B17.6%
2010 A$0.21 B-15.96%
2009 A$0.25 B
2007 -A$62.04 Million40.96%
2006 -A$44.01 Million
2003 -A$51.11 Million34.8%
2002 -A$37.92 Million89.21%
2001 -A$20.04 Million3.93%
2000 -A$19.29 Million21.76%
1999 -A$15.84 Million-25.61%
1998 -A$21.29 Million38.83%
1997 -A$15.34 Million-24.26%
1996 -A$20.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Bio-Rad Laboratories
BIO
-A$1.26 Billion 101.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-A$1.45 Billion 131.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-A$52.05 Million-91.64%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$1.01 B-262.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$12.11 B-2,044.56%๐Ÿ‡บ๐Ÿ‡ธ USA